ADDF-Harrington Scholar Program
Funds academic Alzheimer's researchers with hit-to-lead and development-stage support plus therapeutic guidance.
The ADDF-Harrington Scholar Program is a joint initiative between the Alzheimer's Drug Discovery Foundation and the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, designed to bridge the gap between academic discovery and pharmaceutical-grade drug development for Alzheimer's disease and related dementias. Unlike ADDF's broader RFPs, this is a dedicated scholar program th…
Hit-to-lead optimization through IND-enabling studies for Alzheimer's and related dementias. High-priority targets: proteostasis (autophagy, lysosomal) and senescence. No anti-amyloid or cholinesterase inhibitor approaches.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
Write proposalGrant Letter of Intent: How to Write an LOI or Letter of Inquiry
Learn what a grant letter of intent is, when funders ask for LOIs or letters of inquiry, what to include, what to avoid, and how funder rules differ.
More from ADDF
All grants from this funder →ADDF Drug Development RFP
ADDF · Global / Multinational
Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.
ADDF Neuroimaging and CSF Biomarker RFP
ADDF · Global / Multinational
Funds new biomarkers for Alzheimer's and related dementias through PET ligands, MRI, spinal fluid, and brain activity measures.
ADDF Prevention RFP
ADDF · Global / Multinational
Supports dementia prevention research through precision risk reduction, combination treatment testing, and effectiveness comparisons.
Accelerating Drug Discovery for FTD RFP
ADDF · Global / Multinational
Funds lead optimization and in vivo testing for frontotemporal dementia candidates, including medicinal chemistry and preclinical studies.
Treat FTD Fund
ADDF · Global / Multinational
Funds early-stage clinical studies for frontotemporal dementia, including prevention trials for high-risk participants.
Similar grants
Browse the directory →
Bexar County Skills Development Program
🇺🇸Bexar Innovation Fund · United States
Funds Bexar County companies expanding targeted-industry jobs through workforce training grants.
NIOSH WTC Health Program — R21 Exploratory Grant
🇺🇸NIOSH · United States
Funds exploratory clinical studies improving diagnostics and treatments from disaster-related conditions.
NIH IGNITE Program — R61/R33 Phased Neurotherapeutic Grants
🇺🇸NIH · United States
Supports early neurotherapeutic translation through milestone-based translational funding.
Project Award
🇬🇧ARUK · United Kingdom
Funds major dementia research programs in the United Kingdom through multi-year grants.
BHF Project Grants
🇬🇧BHF · United Kingdom
Funds cardiovascular project grants for discovery science in the United Kingdom.
Damon Runyon Physician-Scientist Training Award
🇺🇸Damon Runyon · United States
Supports clinical physicians transitioning into full-time cancer laboratory research through physician-scientist training.